@article{658fde0ed2f644bd8d0c82f54994a93b,
title = "Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi: Bone Marrow Transplantation",
keywords = "bendamustine, CD34 antigen, cytarabine, fludarabine, granulocyte colony stimulating factor, ibritumomab tiuxetan, platinum complex, plerixafor, rituximab, autologous stem cell transplantation, bone marrow, cancer immunotherapy, cell count, drug megadose, engraftment, follicular lymphoma, human, indolent nonhodgkin lymphoma, Italy, Letter, marginal zone lymphoma, nonhodgkin lymphoma, overall survival, peripheral blood stem cell, pneumonia, priority journal, relapse, sepsis, stem cell mobilization, Waldenstroem macroglobulinemia",
author = "M. Merli and S. Luminari and L. Farina and F. Cocito and I. Defrancesco and G. Gini and A. Arcari and G. Scapinello and M. Gentile and M. Goldaniga and G. Loseto and E. Cencini and A. Greco and A.L. Molinari and A. Ferrario and B. Bianchi and B. Mora and L. Bert{\`u} and V. Saturni and F. Bergamini and N. Fabbri and F.G. Rossi and S. Bolis and F. Passamonti and L. Arcaini",
note = "Export Date: 22 January 2021 CODEN: BMTRE Correspondence Address: Merli, M.; Hematology, Italy; email: michele.merli@asst-settelaghi.it",
year = "2020",
doi = "10.1038/s41409-020-0967-5",
language = "English",
volume = "55",
pages = "2350--2353",
journal = "Bone Marrow Transplant.",
issn = "0268-3369",
publisher = "Springer Nature",
number = "12",
}